Published in Ther Clin Risk Manag on June 19, 2012
Myofascial pain syndrome: a treatment review. Pain Ther (2013) 0.80
Deconstructing Chronic Low Back Pain in the Older Adult: Step by Step Evidence and Expert-Based Recommendations for Evaluation and Treatment: Part IV: Depression. Pain Med (2015) 0.78
Diagnostic reasoning by hospital pharmacists: assessment of attitudes, knowledge, and skills. Can J Hosp Pharm (2012) 0.77
Depression and chronic pain in the elderly: links and management challenges. Clin Interv Aging (2017) 0.75
Duloxetine 60 mg for chronic low back pain: post hoc responder analysis of double-blind, placebo-controlled trials. J Pain Res (2017) 0.75
Response to duloxetine in chronic low back pain: exploratory post hoc analysis of a Japanese Phase III randomized study. J Pain Res (2017) 0.75
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage (2008) 10.99
Diagnosis and treatment of low back pain: a joint clinical practice guideline from the American College of Physicians and the American Pain Society. Ann Intern Med (2007) 9.88
Chapter 4. European guidelines for the management of chronic nonspecific low back pain. Eur Spine J (2006) 8.12
Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature. J Bone Joint Surg Am (2004) 7.59
OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage (2010) 7.52
Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study. Pain (2008) 4.43
Pharmacological management of persistent pain in older persons. J Am Geriatr Soc (2009) 4.43
Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA (2006) 3.49
Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation (2007) 3.27
Sensitization in patients with painful knee osteoarthritis. Pain (2010) 3.18
Will this patient develop persistent disabling low back pain? JAMA (2010) 2.87
Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study. Am J Med (2006) 2.87
EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 2.75
SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectr (2005) 2.71
Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: a 13-week, randomized, placebo-controlled trial. Pain (2009) 2.69
Psychophysical and functional imaging evidence supporting the presence of central sensitization in a cohort of osteoarthritis patients. Arthritis Rheum (2009) 2.29
Acetaminophen for osteoarthritis. Cochrane Database Syst Rev (2006) 2.21
Acetaminophen hepatotoxicity and acute liver failure. J Clin Gastroenterol (2009) 1.97
Pyrolytic carbon proximal interphalangeal joint arthroplasty: results with minimum two-year follow-up evaluation. J Hand Surg Am (2007) 1.88
Pain mechanisms in osteoarthritis: understanding the role of central pain and current approaches to its treatment. J Rheumatol (2011) 1.80
Trends in use of opioids by noncancer pain type 2000-2005 among Arkansas Medicaid and HealthCore enrollees: results from the TROUP study. J Pain (2008) 1.74
Duloxetine added to oral nonsteroidal anti-inflammatory drugs for treatment of knee pain due to osteoarthritis: results of a randomized, double-blind, placebo-controlled trial. Curr Med Res Opin (2011) 1.61
Osteoarthritis and its association with muscle hyperalgesia: an experimental controlled study. Pain (2001) 1.51
Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities. Clin Pharmacol Ther (1992) 1.51
Population-based surveillance for acute liver failure. Am J Gastroenterol (2007) 1.51
A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee. Pain Pract (2011) 1.50
The role of the central nervous system in the generation and maintenance of chronic pain in rheumatoid arthritis, osteoarthritis and fibromyalgia. Arthritis Res Ther (2011) 1.48
Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy. Pain (2012) 1.45
The nerve of osteoarthritis pain. Arthritis Care Res (Hoboken) (2010) 1.39
Osteoarthritis of the hip or knee: which coexisting disorders are disabling? Clin Rheumatol (2010) 1.37
Increased prevalence of metabolic syndrome in individuals with osteoarthritis: an analysis of NHANES III data. Postgrad Med (2009) 1.34
Efficacy and safety of duloxetine in patients with chronic low back pain. Spine (Phila Pa 1976) (2010) 1.24
Randomized controlled trial of diclofenac sodium gel in knee osteoarthritis. Semin Arthritis Rheum (2009) 1.23
Diclofenac sodium gel in patients with primary hand osteoarthritis: a randomized, double-blind, placebo-controlled trial. J Rheumatol (2009) 1.23
Non-steroidal anti-inflammatory drugs and hospitalization for acute renal failure. QJM (1995) 1.21
Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers. J Clin Pharmacol (2009) 1.17
Physical dependence on Ultram (tramadol hydrochloride): both opioid-like and atypical withdrawal symptoms occur. Drug Alcohol Depend (2003) 1.15
Duloxetine versus placebo in patients with chronic low back pain: a 12-week, fixed-dose, randomized, double-blind trial. J Pain (2010) 1.14
Severe tramadol addiction in a 61 year-old woman without a history of substance abuse. Int J Immunopathol Pharmacol (2008) 1.12
A double-blind, randomized trial of duloxetine versus placebo in the management of chronic low back pain. Eur J Neurol (2009) 1.12
Duloxetine: clinical pharmacokinetics and drug interactions. Clin Pharmacokinet (2011) 1.10
A review of the benefits and risks of nonsteroidal anti-inflammatory drugs in the management of mild-to-moderate osteoarthritis. Osteopath Med Prim Care (2009) 1.09
Cardiovascular outcomes in high risk patients with osteoarthritis treated with ibuprofen, naproxen or lumiracoxib. Ann Rheum Dis (2007) 1.09
High tibial osteotomy for the treatment of osteoarthritis of the knee: a review of the literature and a meta-analysis of follow-up studies. Arch Orthop Trauma Surg (2003) 1.09
FDA focuses on drugs and liver damage: labeling and other changes for acetaminophen. JAMA (2009) 1.04
The Diversion of Ultram, Ultracet, and generic tramadol HCL. J Addict Dis (2006) 1.02
Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994-2004. Pharmacoepidemiol Drug Saf (2005) 1.01
A comparison of the efficacy and safety of nonsteroidal antiinflammatory agents versus acetaminophen in the treatment of osteoarthritis: a meta-analysis. Arthritis Rheum (2004) 1.00
Profile of adverse events with duloxetine treatment: a pooled analysis of placebo-controlled studies. Drug Saf (2010) 0.97
A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers. Eur J Clin Pharmacol (1998) 0.95
Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale. Curr Med Res Opin (2004) 0.94
An independent assessment of MEDWatch reporting for abuse/dependence and withdrawal from Ultram (tramadol hydrochloride). Drug Alcohol Depend (2003) 0.92
Lidocaine patch treatment in patients with low back pain: results of an open-label, nonrandomized pilot study. Am J Ther (2005) 0.92
Safety and efficacy of topical diclofenac sodium 1% gel in knee osteoarthritis: a randomized controlled trial. Phys Sportsmed (2010) 0.91
Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the Neuropathic Pain Scale. Curr Med Res Opin (2004) 0.91
Physical dependence potential of daily tramadol dosing in humans. Psychopharmacology (Berl) (2010) 0.90
The reliability and validity of pain threshold measurements in osteoarthritis of the knee. Scand J Rheumatol (1995) 0.89
Gastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase-2 inhibitors in patients on warfarin. Ann Pharmacother (2009) 0.88
Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain. Curr Med Res Opin (2004) 0.87
Duloxetine and care management treatment of older adults with comorbid major depressive disorder and chronic low back pain: results of an open-label pilot study. Int J Geriatr Psychiatry (2010) 0.86
Fibromyalgia syndrome: a discussion of the syndrome and pharmacotherapy. Am J Ther (2010) 0.86
Clinically relevant outcomes based on analysis of pooled data from 2 trials of duloxetine in patients with knee osteoarthritis. J Rheumatol (2011) 0.85
A single-blind, placebo run-in study of duloxetine for activity-limiting osteoarthritis pain. J Pain (2008) 0.82
Increased movement pain in osteoarthritis of the hands is associated with A beta-mediated cutaneous mechanical sensitivity. J Pain (2000) 0.82
Co-morbidities of patients with knee osteoarthritis. Hong Kong Med J (2009) 0.81
Pain threshold analysis in patients with osteoarthrosis of hip. Br Med J (1974) 0.80
Opioid therapy for osteoarthritis and chronic low back pain. Postgrad Med (2010) 0.78
Effect of tens on pain in relation to central sensitization in patients with osteoarthritis of the knee: study protocol of a randomized controlled trial. Trials (2012) 0.78
Two to five year follow-up of the LPM ceramic coated proximal interphalangeal joint arthroplasty. J Hand Surg Eur Vol (2008) 0.78
Duloxetine: in patients with fibromyalgia. Drugs (2009) 0.77
Tramadol addiction. J Fam Pract (2005) 0.76
Duloxetine in treatment of refractory chronic tennis elbow: two case reports. J Med Case Rep (2008) 0.76
A Kaposi's sarcoma-associated herpesviral protein inhibits virus-mediated induction of type I interferon by blocking IRF-7 phosphorylation and nuclear accumulation. Proc Natl Acad Sci U S A (2002) 2.30
Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochim Biophys Acta (2009) 2.05
Segmentation of intra-retinal layers from optical coherence tomography images using an active contour approach. IEEE Trans Med Imaging (2010) 1.39
Is alpha-lipoic acid a scavenger of reactive oxygen species in vivo? Evidence for its initiation of stress signaling pathways that promote endogenous antioxidant capacity. IUBMB Life (2008) 1.15
Passage of Campylobacter jejuni through the chicken reservoir or mice promotes phase variation in contingency genes Cj0045 and Cj0170 that strongly associates with colonization and disease in a mouse model. Microbiology (2012) 0.92
Transcriptional regulation of rat gamma-glutamate cysteine ligase catalytic subunit gene is mediated through a distal antioxidant response element. Pharmacol Res (2009) 0.85
(R)-α-Lipoic acid treatment restores ceramide balance in aging rat cardiac mitochondria. Pharmacol Res (2010) 0.84
R-α-lipoic acid does not reverse hepatic inflammation of aging, but lowers lipid anabolism, while accentuating circadian rhythm transcript profiles. Am J Physiol Regul Integr Comp Physiol (2011) 0.84
Development of a hyena immunology toolbox. Vet Immunol Immunopathol (2011) 0.80
Transcription factor Nrf2: examination of nuclear protein levels by immunoblotting and promoter response element binding by chromatin immunoprecipitation (ChIP). Curr Protoc Toxicol (2010) 0.77
Autoimmune Pancreatitis Presenting with Mass and Biliary Obstruction. Radiol Case Rep (2015) 0.75
Regularly irregular narrow complex tachycardia: what is the mechanism? Heart Rhythm (2008) 0.75